J&J, Janssen Agree to Settle Risperdal Lawsuit in Montana for $5.9 Million
A Risperdal lawsuit settlement has been reached in Montana for more than $5.9 million, its Attorney General’s Office reports.
According to a March 6th announcement by the Montana Department of Justice, an agreement was reached in February by Johnson & Johnson and Janssen Ortho LLC over their allegedly illegal and deceptive marketing of Risperdal.
The suit was originally filed in 2008 against the makers of this medication, according to Attorney General Tim Fox, who were accused of promoting the atypical antipsychotic drug as safe and effective for a range of conditions that may not have included its U.S. Food and Drug Administration (FDA) approved uses.
Reached in February, the $5.9 million settlement orders that Janssen refrain from making misleading claims in the marketing of Risperdal and other drugs, and be transparent in disclosing possible side effect information to the general public. Despite its agreement to resolve claims filed over Risperdal and other drugs, Janssen says the committed no wrongdoing in the marketing of its products.
In more than 200 lawsuits now filed in the Philadelphia Court of Common Pleas, men and young boys allege male breast development and other complications stemming from this medication. Court documents indicate that Risperdal gynecomastia claims pending in the consolidated Pennsylvania court litigation allege Johnson & Johnson and Janssen’s failure to adequately warn patients about dangers associated with the antipsychotic drug, which was designed defectively.
Risperdal Settlement Funds Allocated to Drug Abuse Prevention Program, Montana Mental Health Services
In Montana, Attorney General Fox said $1.5 million of the settlement will help fund a new Prescription Drug Abuse Prevention Program, for which a public education specialist will be hired to create a student education program that will fuel public awareness on the dangers of prescription drug addiction.
“Almost eight percent of Montana’s youth between the ages of 12 – 17 recently reported abusing prescription drugs,” General Fox said. “We need to do more to educate them, and their parents, about the dangers of these drugs.”
Another $1.5 billion will be used for mental health services and programs through the Montana Mental Health Trust, according to the agreement.
Contact our Firm to File a Risperdal Lawsuit
If you or a loved one experienced a side effect after taking Risperdal, call our Firm today to file a lawsuit. We can be reached directly at (877) 779-1414.